The STARD-AI reporting guideline provides a standardized framework for researchers to improve the transparency and reproducibility of diagnostic accuracy studies involving artificial intelligence. Published in Nature Medicine, the initiative addresses …
Tag:
Molecular Medicine
-
-
Targeting GNAQ/GNA11 Mutations: Progress in Metastatic Uveal Melanoma Treatment Researchers are evaluating the antibody-drug conjugate (ADC) DYP688 as a potential treatment for patients with GNAQ/GNA11-mutant metastatic uveal melanoma or other …
-
Advancements in Gene Therapy for Congenital Deafness: Sequential Bilateral Treatment Recent clinical progress in gene therapy for genetic hearing loss demonstrates that sequential bilateral treatment is both safe and effective, …
-
2024 McDonald Criteria Revisions: Advances in Multiple Sclerosis Diagnosis The 2024 revisions to the McDonald criteria represent a significant evolution in the diagnosis of multiple sclerosis (MS), aiming to facilitate …
-
Clinical Trial NCT02658981: Investigating Relatlimab for Recurrent Glioblastoma A multicenter, phase 1 clinical trial (NCT02658981), conducted under the NCI Adult Brain Tumor Consortium (ABTC), evaluated the safety and immunological impact …
-
NeuroVFM: Advancing Medical Imaging Through Health System Learning Researchers at the University of Michigan have developed NeuroVFM, a generalist medical foundation model designed to interpret neuroimaging data directly from routine …
-
Pancreatic cancer treatment is shifting toward precision medicine as new inhibitors target the KRAS G12D mutation, a primary driver in over 90% of pancreatic ductal adenocarcinomas (PDAC). Recent clinical data …
-
Health
Safety and Feasibility of STEM-PD Stem Cell Transplantation for Parkinson’s Disease: A First-in-Human Trial
STEM-PD Clinical Trial: First-in-Human Results for Parkinson’s Disease Cell Therapy A first-in-human clinical trial of STEM-PD—a cell therapy derived from human embryonic stem cells—has demonstrated initial safety and tolerability in …
-
The Science of Biological Aging: Beyond Chronological Time Biological aging is a dynamic process characterized by the gradual decline of physiological functions and the accumulation of molecular damage, which researchers …
-
As cancer survival rates improve through targeted therapies like immunotherapies and antibody-drug conjugates, the medical community faces a growing challenge in recording and managing long-term treatment toxicities. Current reporting frameworks, …
Newer Posts